{
  "id": "clinical#screening_cues_daa0b038",
  "content": "Boundary with anxiety symptoms caused by substances or medications, including\nwithdrawal effects\nWhen establishing a diagnosis of secondary anxiety syndrome, it is important to rule out the\npossibility that a medication or substance is causing the anxiety symptoms instead of – or in\naddition to – an underlying medical condition. This involves first considering whether any of the\nmedications being used to treat the medical condition are known to cause anxiety symptoms at\nthe dose and duration at which it has been administered. Second, a temporal relationship between\nthe medication use and the onset of the anxiety symptoms should be established (i.e. the anxiety\nsymptoms began after administration of the medication and/or remitted once the medication was\ndiscontinued). The same reasoning applies to individuals with a medical condition and anxiety\nsymptoms who are also using a psychoactive substance known to cause anxiety, in the context\nof either intoxication or withdrawal (e.g. panic attacks during anxiolytic or opioid withdrawal,\nphysiological symptoms of excessive autonomic arousal in stimulant intoxication). In such\ncases, if the intensity or duration of the anxiety symptoms is substantially in excess of anxiety\nsymptoms that are characteristic of the substance-specific intoxication or withdrawal syndrome,",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "communication_tips",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues Boundary with anxiety symptoms caused by substances or medications, including\nwithdrawal effects\nWhen establishing a diagnosis of secondary anxiety syndrome, it is important to rule out the\npossibility that a medication or substance is causing the anxiety symptoms instead of – or in\naddition to – an underlying medical condition. This involves first considering whether any of the\nmedications being used to treat the medical condition are known to cause anxiety symptoms at\nthe dose and duration at which it has been administered. Second, a temporal relationship between\nthe medication use and the onset of the anxiety symptoms should be established (i.e. the anxiety\nsymptoms began after administration of the medication and/or remitted once the medication was\ndiscontinued). The same reasoning applies to individuals with a medical condition and anxiety\nsymptoms who are also using a psychoactive substance known to cause anxiety, in the context\nof either intoxication or withdrawal (e.g. panic attacks during anxiolytic or opioid withdrawal,\nphysiological symptoms of excessive autonomic arousal in stimulant intoxication). In such\ncases, if the intensity or duration of the anxiety symptoms is substantially in excess of anxiety\nsymptoms that are characteristic of the substance-specific intoxication or withdrawal syndrome, Ranh giới with lo âu symptoms caused by substances or medications, including\nwithdrawal effects\nwhen establishing a diagnosis of secondary lo âu syndrome, it is important to rule out the\npossibility that a medication or ..."
}